Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism

Marilene Demasi1, Kelvin J A Davies

  • 1Ethel Percy Andrus Gerontology Center, and Division of Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089-0191, USA. mari_masi@hotmail.com

FEBS Letters
|May 6, 2003
PubMed

Insights

Proteasome inhibitors induce oxidative stress and cell death in liver cells, but this effect is significantly reduced under low oxygen conditions, suggesting an oxygen-dependent mechanism.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Toxicology

Background:

  • Proteasome inhibitors are used in cancer therapy but can cause cellular damage.
  • Oxidative stress is implicated in various cellular dysfunctions and diseases.
  • The role of oxygen levels in proteasome inhibitor-induced toxicity is not fully understood.

Purpose of the Study:

  • To investigate the impact of proteasome inhibitors on liver cells under varying oxygen conditions.
  • To elucidate the mechanism behind proteasome inhibitor-induced oxidative protein modifications and cell death.

Main Methods:

  • Clone 9 liver cells were treated with proteasome inhibitors (lactacystin, clastro lactacystin beta-lactone, tri-leucine vinyl sulfone).
  • Cells were incubated under standard (21%) and low (3%) oxygen atmospheres.
  • Oxidative protein modifications (solubility, aggregation, carbonyl formation), cell morphology, and viability were assessed.

Main Results:

  • Proteasome inhibitors induced oxidative protein modifications and reduced cell viability under 21% oxygen.
  • These effects were similar to those caused by hydrogen peroxide treatment.
  • Almost all inhibitor-induced alterations were prevented under 3% oxygen.

Conclusions:

  • Proteasome inhibitor-induced protein oxidation, aggregation, and apoptosis are oxygen-dependent.
  • This suggests a critical role for oxygen in the cellular toxicity of proteasome inhibitors.
  • Manipulating oxygen levels may offer a strategy to mitigate proteasome inhibitor side effects.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...